TY - JOUR
T1 - New Hope in the Search for Ebola Virus Treatments
AU - Basler, Christopher F.
N1 - Funding Information:
The author thanks Christine Schwall for critical reading of the manuscript and the National Institutes of Health (R01AI05953, U19AI109945, and U19AI109664) and the Department of the Defense, Defense Threat Reduction Agency (HDTRA1-12-1-0051 and HDTRA1-14-1-0013) for financial support. The content of the information does not necessarily reflect the position or the policy of the federal government, and no official endorsement should be inferred.
Publisher Copyright:
© 2014 Elsevier Inc.
PY - 2014/10/16
Y1 - 2014/10/16
N2 - Because of its lethality, the Ebola virus often appears to be an invincible adversary. In Nature, Qiu etal. (2014) recently described the complete protection of nonhuman primates from deadly Ebola virus disease, even when treatment was begun as late as 5days after infection. Because of its lethality, the Ebola virus often appears to be an invincible adversary. In Nature, Qiu etal. recently described the complete protection of nonhuman primates from deadly Ebola virus disease, even when treatment was begun as late as 5days after infection.
AB - Because of its lethality, the Ebola virus often appears to be an invincible adversary. In Nature, Qiu etal. (2014) recently described the complete protection of nonhuman primates from deadly Ebola virus disease, even when treatment was begun as late as 5days after infection. Because of its lethality, the Ebola virus often appears to be an invincible adversary. In Nature, Qiu etal. recently described the complete protection of nonhuman primates from deadly Ebola virus disease, even when treatment was begun as late as 5days after infection.
UR - http://www.scopus.com/inward/record.url?scp=84908137520&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2014.10.001
DO - 10.1016/j.immuni.2014.10.001
M3 - Short survey
C2 - 25367568
AN - SCOPUS:84908137520
SN - 1074-7613
VL - 41
SP - 515
EP - 517
JO - Immunity
JF - Immunity
IS - 4
ER -